Bausch Health Companies Inc

NYSE:BHC   2:30:42 PM EDT
8.33
+0.38 (+4.78%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)3.06B
Current PEN/A
Forward PE 2.31
2yr Forward PE 2
See more stats
Estimates Current Quarter
Revenue$2.42 Billion
Adjusted EPS$1.04
See more estimates
10-Day MA$8.10
50-Day MA$6.76
200-Day MA$7.65
See more pivots

Bausch Health Companies Inc Stock, NYSE:BHC

2150 St. Elz�©ar Boulevard West, Laval, Qu�©bec H7L 4A8
Canada
Phone: +1.514.744.6792
Number of Employees: 20270

Description

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada.